RxDoctor Payments Data

Benjamin Swisher, MD

Family Medicine · Canton, OHNPI 1518923788

Payments from drug & device makers

$16,099in general payments, 2019–2025

Across 1,210 payments — averaging $13.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Pfizer$2K
  • Boehringer Ingelheim$1K
  • GSK$1K
  • Novo Nordisk$1K
  • plus $7K from 54 others

What the payments were for

  • Food & beverage$16,092100%
  • Education$70%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)212$2,344
AstraZeneca99$1,841
Pfizer167$1,615
Boehringer Ingelheim103$1,284
GSK79$1,026
Novo Nordisk73$1,004
Lilly USA, LLC64$836
Merck48$583
Teva Pharmaceuticals USA, Inc.46$564
Johnson & Johnson24$405
Takeda Pharmaceuticals U.S.A., Inc.24$395
Novartis24$282
Astellas Pharma US Inc16$262
Biohaven Pharmaceutical Holding Company Ltd.19$241
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC16$228
Exact Sciences13$214
Biohaven Pharmaceuticals, Inc.14$205
Xeris Pharmaceuticals, Inc.11$186
Supernus Pharmaceuticals, Inc.11$172
Amgen9$150
Axsome Therapeutics, Inc.8$148
Sunovion Pharmaceuticals Inc.13$143
Amarin Pharma, Inc.10$139
E.r. Squibb & Sons, L.L.C.8$131
Vanda Pharmaceuticals Inc.7$129
Bayer6$109
Dexcom, Inc.6$100
Idorsia Pharmaceuticals US Inc6$90
Corium, LLC4$78
Ironwood Pharmaceuticals, Inc5$78
Sumitomo Pharma America, Inc.4$77
Eisai Inc.4$69
Phathom Pharmaceuticals, Inc.4$63
Nestle Healthcare Nutrition Inc.4$63
Optinose US, Inc.3$62
Abbott3$62
Genentech USA, Inc.4$61
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$57
Verona Pharma, Inc.2$53
Gilead3$51
Sage Therapeutics, LLC3$51
Scynexis, Inc.3$50
Ironshore Pharmaceuticals Inc.3$48
Seqirus USA Inc2$34
Jazz Pharmaceuticals Inc.2$30
Avanir Pharmaceuticals, Inc.2$29
Sun Pharmaceutical Industries Inc.2$26
Inspire Medical Systems, Inc.1$25
Cipher Pharmaceuticals US LLC1$25
Mycovia Pharmaceuticals, Inc.1$22
Tris Pharma Inc1$22
Tonix Medicines, Inc.1$20
Corcept Therapeutics1$19
Medtronic1$18
Collegium Pharmaceutical, Inc.1$15
Amneal Pharmaceuticals LLC1$15
Endo Pharmaceuticals Inc.1$13
Upsher-smith Laboratories LLC1$12
Bausch Health US, LLC1$11
Currax Pharmaceuticals LLC1$11

How this compares

$16,099 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$64,218
Medicare patients
132
Services billed
1,532

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban103$84,589
TrulicityDulaglutide52$65,713
AustedoDeutetrabenazine12$62,382
JardianceEmpagliflozin67$53,938
OzempicSemaglutide55$51,789
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$27,308
TradjentaLinagliptin14$16,146
FanaptIloperidone14$14,770
JanuviaSitagliptin Phosphate15$14,091
FarxigaDapagliflozin Propanediol21$13,464
XareltoRivaroxaban16$11,731
Breo ElliptaFluticasone/Vilanterol24$9,989
MyrbetriqMirabegron16$7,412
LinzessLinaclotide12$7,178
OxycontinOxycodone Hcl12$6,587

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$1,615$84,589103 claims
Boehringer IngelheimJardiance, Tradjenta$1,284$70,08481 claims
Lilly USA, LLCTrulicity$836$65,71352 claims
Teva Pharmaceuticals USA, Inc.Austedo$564$62,38212 claims
Novo NordiskOzempic$1,004$51,78955 claims
GSKTrelegy Ellipta, Breo Ellipta$1,026$37,29764 claims
MerckJanuvia, Steglatro$583$17,87027 claims
Vanda Pharmaceuticals Inc.Fanapt$129$14,77014 claims
AstraZenecaFarxiga$1,841$13,46421 claims
Johnson & JohnsonXarelto$405$11,73116 claims
Astellas Pharma US IncMyrbetriq$262$7,41216 claims
AbbVieLinzess$2,344$7,17812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →